FORTRESS BIOTECH INC's ticker is FBIO and the CUSIP is 34960Q109. A total of 74 filers reported holding FORTRESS BIOTECH INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $580,600 | -68.1% | 2,000,000 | -39.6% | 0.19% | -56.6% |
Q2 2023 | $1,820,500 | -51.5% | 3,310,000 | -27.6% | 0.44% | -61.3% |
Q1 2023 | $3,750,352 | +179.3% | 4,573,600 | +123.1% | 1.12% | +140.5% |
Q4 2022 | $1,342,750 | -47.9% | 2,050,000 | -31.6% | 0.47% | -56.2% |
Q3 2022 | $2,579,000 | -5.4% | 2,999,000 | -7.6% | 1.06% | -13.3% |
Q2 2022 | $2,727,000 | -46.5% | 3,247,180 | -13.4% | 1.23% | -22.4% |
Q1 2022 | $5,100,000 | -45.6% | 3,750,000 | 0.0% | 1.58% | -20.3% |
Q4 2021 | $9,375,000 | -22.4% | 3,750,000 | 0.0% | 1.99% | -11.8% |
Q3 2021 | $12,075,000 | -12.7% | 3,750,000 | -3.2% | 2.26% | -1.9% |
Q2 2021 | $13,834,000 | +1.1% | 3,875,000 | 0.0% | 2.30% | +14.4% |
Q1 2021 | $13,679,000 | +11.0% | 3,875,000 | -0.3% | 2.01% | +24.8% |
Q4 2020 | $12,323,000 | +20.1% | 3,887,500 | +1.5% | 1.61% | -19.8% |
Q3 2020 | $10,264,000 | 0.0% | 3,830,000 | 0.0% | 2.01% | -3.2% |
Q2 2020 | $10,264,000 | +616.3% | 3,830,000 | +1115.9% | 2.07% | +405.6% |
Q1 2018 | $1,433,000 | – | 315,000 | – | 0.41% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Opaleye Management Inc. | 2,000,000 | $580,600 | 0.19% |
Nantahala Capital Management | 6,018,211 | $1,747,087 | 0.15% |
THOMPSON DAVIS & CO., INC. | 12,996 | $3,773 | 0.01% |
Platform Technology Partners | 30,000 | $8,709 | 0.00% |
Black Maple Capital Management LP | 15,000 | $4,355 | 0.00% |
Arete Wealth Advisors, LLC | 52,547 | $15,254 | 0.00% |
B. Riley Wealth Advisors, Inc. | 144,700 | $42,006 | 0.00% |
ACADIAN ASSET MANAGEMENT LLC | 1,075,531 | $311 | 0.00% |
WEALTH ENHANCEMENT ADVISORY SERVICES, LLC | 1,542,000 | $447,643 | 0.00% |
GROUP ONE TRADING, L.P. | 2,000 | $581 | 0.00% |